Cost-effectiveness analysis of colorectal cancer screening in Shanghai, China: A modelling study.

Autor: Wang J; Department of Preventive Medicine and Health Education, School of Public Health, Fudan Health Communication Institute, Fudan University, Shanghai, China., de Jonge L; Erasmus MC, University Medical Center Rotterdam, Department of Public Health, Rotterdam, The Netherlands., Cenin DR; Erasmus MC, University Medical Center Rotterdam, Department of Public Health, Rotterdam, The Netherlands.; Centre for Health Services Research, School of Population and Global Health, The University of Western Australia, Perth, Western Australia, Australia., Li P; The Center for Disease Prevention and Control Huangpu, Shanghai, China., Tao S; Department of Preventive Medicine and Health Education, School of Public Health, Fudan Health Communication Institute, Fudan University, Shanghai, China., Yang C; Shanghai Pudong New Area Center for Disease Control and Prevention, Shanghai, China., Yan B; Shanghai Pudong New Area Center for Disease Control and Prevention, Shanghai, China.; Xi'an International Medical Center Hospital, Xi'an, China., Lansdorp-Vogelaar I; Erasmus MC, University Medical Center Rotterdam, Department of Public Health, Rotterdam, The Netherlands.

Publikováno v: Preventive medicine reports [Prev Med Rep] 2022 Jul 04; Vol. 29, pp. 101891. Date of Electronic Publication: 2022 Jul 04 (Print Publication: 2022).

Cost-Effectiveness of Personalized Screening for Colorectal Cancer Based on Polygenic Risk and Family History.

Autor: Cenin DR; Erasmus MC, University Medical Center Rotterdam, Department of Public Health, Rotterdam, the Netherlands. d.cenin@erasmusmc.nl.; Centre for Health Services Research, School of Population and Global Health, The University of Western Australia, Perth, Western Australia, Australia.; Health Systems and Health Economics, School of Public Health, Faculty of Health Sciences, Curtin University, Perth, Western Australia, Australia., Naber SK; Erasmus MC, University Medical Center Rotterdam, Department of Public Health, Rotterdam, the Netherlands., de Weerdt AC; Erasmus MC, University Medical Center Rotterdam, Department of Public Health, Rotterdam, the Netherlands., Jenkins MA; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia., Preen DB; Centre for Health Services Research, School of Population and Global Health, The University of Western Australia, Perth, Western Australia, Australia., Ee HC; Department of Gastroenterology, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia., O'Leary PC; Health Systems and Health Economics, School of Public Health, Faculty of Health Sciences, Curtin University, Perth, Western Australia, Australia.; Division of Obstetrics and Gynaecology, Faculty of Health and Medical Sciences, The University of Western Australia, Perth, Western Australia, Australia.; Clinical Biochemistry, PathWest Laboratory Medicine, QE2 Medical Centre, Nedlands, Western Australia, Australia., Lansdorp-Vogelaar I; Erasmus MC, University Medical Center Rotterdam, Department of Public Health, Rotterdam, the Netherlands.

Publikováno v: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology [Cancer Epidemiol Biomarkers Prev] 2020 Jan; Vol. 29 (1), pp. 10-21. Date of Electronic Publication: 2019 Nov 20.

Costs and outcomes of Lynch syndrome screening in the Australian colorectal cancer population.

Autor: Cenin DR; Department of Public Health, Erasmus Medical Center, Rotterdam, The Netherlands.; Faculty of Health Sciences, Curtin University, Perth, Western Australia, Australia.; Centre for Health Services Research, School of Population and Global Health, The University of Western Australia, Perth, Western Australia, Australia., Naber SK; Department of Public Health, Erasmus Medical Center, Rotterdam, The Netherlands., Lansdorp-Vogelaar I; Department of Public Health, Erasmus Medical Center, Rotterdam, The Netherlands., Jenkins MA; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia., Buchanan DD; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia.; Colorectal Oncogenomics Group, Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, Victoria, Australia.; Genetic Medicine and Familial Cancer Centre, The Royal Melbourne Hospital, Parkville, Victoria, Australia.; Victorian Comprehensive Cancer Centre, University of Melbourne Centre for Cancer Research, Parkville, Victoria, Australia., Preen DB; Centre for Health Services Research, School of Population and Global Health, The University of Western Australia, Perth, Western Australia, Australia., Ee HC; Department of Gastroenterology, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia., O'Leary P; Faculty of Health Sciences, Curtin University, Perth, Western Australia, Australia.; School of Women's and Infants' Health, The University of Western Australia, Perth, Western Australia, Australia.; PathWest Laboratory Medicine, QE2 Medical Centre, Nedlands, Western Australia, Australia.

Publikováno v: Journal of gastroenterology and hepatology [J Gastroenterol Hepatol] 2018 Oct; Vol. 33 (10), pp. 1737-1744. Date of Electronic Publication: 2018 May 17.

Cost-Effectiveness of Screening Individuals With Cystic Fibrosis for Colorectal Cancer.

Autor: Gini A; Department of Public Health, Erasmus Medical Center, University Medical Center Rotterdam, Rotterdam, The Netherlands. Electronic address: a.gini@erasmusmc.nl., Zauber AG; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York., Cenin DR; Department of Public Health, Erasmus Medical Center, University Medical Center Rotterdam, Rotterdam, The Netherlands; Faculty of Health Sciences, Curtin University, Perth, Western Australia, Australia., Omidvari AH; Department of Public Health, Erasmus Medical Center, University Medical Center Rotterdam, Rotterdam, The Netherlands., Hempstead SE; Cystic Fibrosis Foundation, Bethesda, Maryland., Fink AK; Cystic Fibrosis Foundation, Bethesda, Maryland., Lowenfels AB; Department of Surgery, New York Medical College, Valhalla, New York; Department of Family Medicine, New York Medical College, Valhalla, New York., Lansdorp-Vogelaar I; Department of Public Health, Erasmus Medical Center, University Medical Center Rotterdam, Rotterdam, The Netherlands.

Publikováno v: Gastroenterology [Gastroenterology] 2017 Dec 27. Date of Electronic Publication: 2017 Dec 27.

Long-term evaluation of benefits, harms, and cost-effectiveness of the National Bowel Cancer Screening Program in Australia: a modelling study.

Autor: Lew JB; Cancer Research Division, Cancer Council NSW, NSW, Australia; Prince of Wales Clinical School, University of NSW, NSW, Australia. Electronic address: jiebin.lew@nswcc.org.au., St John DJB; Prevention Division, Cancer Council Victoria, VIC, Australia; Department of Medicine, The Royal Melbourne Hospital, The University of Melbourne, VIC, Australia., Xu XM; Prince of Wales Clinical School, University of NSW, NSW, Australia., Greuter MJE; Epidemiology and Biostatistics, VU Medical Center, Boelelaan, Amsterdam, Netherlands., Caruana M; Cancer Research Division, Cancer Council NSW, NSW, Australia; Prince of Wales Clinical School, University of NSW, NSW, Australia., Cenin DR; Faculty of Health Sciences, Curtin University, WA, Australia; Department of Public Health, Erasmus Medical Center, Rotterdam, Netherlands., He E; Cancer Research Division, Cancer Council NSW, NSW, Australia; Prince of Wales Clinical School, University of NSW, NSW, Australia., Saville M; Victorian Cytology Service Ltd, Carlton South, VIC, Australia; Department of Obstetrics and Gynaecology, University of Melbourne, VIC, Australia., Grogan P; Advocacy, Cancer Council Australia, Sydney, NSW, Australia., Coupé VMH; Epidemiology and Biostatistics, VU Medical Center, Boelelaan, Amsterdam, Netherlands., Canfell K; Cancer Research Division, Cancer Council NSW, NSW, Australia; Prince of Wales Clinical School, University of NSW, NSW, Australia; School of Public Health, Sydney Medical School, University of Sydney, NSW, Australia.

Publikováno v: The Lancet. Public health [Lancet Public Health] 2017 Jul; Vol. 2 (7), pp. e331-e340. Date of Electronic Publication: 2017 Jun 26.